Dr. Amita Mahajan

Dr. Amita Mahajan

Dr. Amita Mahajan



23 years +

Indraprastha Apollo Hospitals, Sarita Vihar, Delhi-mathura Road, New Delhi - 110076. India

Presently Working in Apollo Hospitals since last Assignment

  • Royal College of Paediatrics & Child Health
  • UK Children’s Cancer Study Group
  • International Society Of Paediatrics
  • Oncology Indian Academy Of Pediatrics
  • Thalassemics IndiaFoundation Against
  • Thalassemia Can Support,CanKids

Research And Publications

Thawani R, Moghe A, Idhate T, Kalra M, Mahajan A, Anderson KE. Porphyria Cutanea Tarda in a child with Acute Lymphoblastic Leukemia. QJM 2015,Dhamija M, Mahajan A, Kalra M, Virmani A. Deferasirox in Indian children with thalassemia major: 3 years experience. Indian J Med Paediatr Oncol. 2013 Jan-Mar; 34(1): 16–20,Mittal L, Kalra M, Mahajan A. Study of Feasibility and Acceptability of Subcutaneous Implantable Ports (SIPs) in Cancer Patients. Indian J Pediatr 2012; 79(12): 1601-1604. Fauzdar A, Mahajan A, Jain D, Mishra M, Raina V. Amplification of RUNX1 gene in two cases of childhood B-cell precursor acute lymphoblastic leukemia J Clin Oncol 2009; Suppl: abstr e21000,Fauzdar A, jain D, Mishra M, Gupta N, Bhurani D, Mishra P, Mahajan A, raina V. Molecular cytogenetic study in pediatric b-lineage acute lymhoblastic leukemia: A collaborative study group from North India. J Clin Oncol 2008; Suppl: abstr e20001.Mahajan A, Faisal , Raina V. Acute Lymphoblastic leukemia: Improving outcomes in the Indian Scenario. Pediatr Blood & Cancer 2008; 48.Mahajan A, Sharma P. Pasha F. Feasibility of implantable ports in the Indian Scenario. Pediatr Blood & Cancer 2007; 49: PG.045.Mahajan A, Gupta V, Sharma P. A study of the profile of CNS tumors presenting to a new Pediatric Oncology Service in India. Pediatr Blood & Cancer 2006; 47: PJ.015.Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A, Lang D,Fischer A, Friedrich W, Schulz AS: Working Party on Inborn Errors of the European Blood & Marrow Transplant Group. Severe Pulmonary Hypertension: A Frequent Complication of Stem Cell Transplantation for Malignant Infantile Osteopetrosis. Br J Haematol 2004; 124(1): 63-71.

Booms C, Mahajan A, Jenney ME. Outcome of catheter related sepsis in pediatric oncology patients. Arch Dis Child 2002; A14:G20.Mahajan A, Jenney ME, Doull I, Westmoreland D. RSV Bronchiolitis in immunocompromised host- the role of ribavirin? Published in the Welsh Pediatric Journal, May 2002.Mahajan A, Nirmal S, English MW, Jenney ME, Lazda E. Acute Tumour lysis in Hodgkin’s disease. Med Pediatr Oncol 2002; 39(1): 69-70.Mahajan A, Foot AB, English MW, Jenney ME. Survey of immunisation practices following completion of chemotherapeutic treatment. Arch Dis Child 2001; 84 (Suppl I): A29. Chowdhry VP, Lal A, Pati HP, Arya LS. Hematological responses to hydroxyurea therapy in multitransfused thalassemic children. Indian J Pediatrics 1997: 64(3): 395-8.Lal A, Pati HP, Arya LS, Chowdhry VP. Effect of Myleran Therapy in Multitransfused Beta-Thalassemic Children. Indian Paediatrics 1995; 32(2): 238-41.

Quick Book

Request A Call Back